IP Library Patent Application 11953120
Patent Application
App. No. 11/953,120

COMPOSITIONS FOR DENTAL COMPOSITES WITH TRICYCLO[5.2.1.02.6]DECANE DERIVATIVES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/953,120
Abstract

Compositions for dental composites comprising monomers, crosslinking agents, fillers, initiators, A the proportion of crosslinking agent being formed in an amount of more than 50% by acrylate monomers with a TCD urethane structure having the general formula in which A, X, Z, R1 R2 R3 and r have the meaning indicated in claim 1, provide polymerized composite materials with a particularly low cytotoxicity according to the standard requirements according to ISO 10993-5 and DIN EN ISO 7405.

Claims (18)

1 . Dental composites comprising

monomers,

crosslinking agents,

fillers,

initiators, wherein

A: the proportion of crosslinking agent is formed in an amount of more than 50% by acrylate monomers with a TCD urethane structure having the general formula

in which

A is a straight-chain or branched aliphatic radical with 2 to 20 carbon atoms, the radical containing, optionally, 1 to 3 oxygen bridges, an aromatic radical with 6 to 24 carbon atoms, an araliphatic radical with 7 to 26 carbon atoms or a cycloaliphatic radical with 6 to 26 carbon atoms,

r represents the number of chains issuing from A and an integer of 2 to 6,

R 1 and R 2 are identical and represent hydrogen or are different and represent hydrogen and methyl,

n represents, for each chain issuing from A, independently an integer of 0 to 5,

X represents the group

in which

R 4 and R 5 are identical or different and represent hydrogen, halogen, lower alkoxy, lower alkyl or trifluoromethyl,

Z may contain a divalent straight-chain or branched aliphatic hydrocarbon radicals of 3 to 15 carbon atoms which, optionally, may contain 1 to 3 oxygen bridges atoms and, optionally, may be substituted by 1 to 4 additional (meth)acrylate radicals, R 2 , R 3 are exclusively hydrogen, and

B exhibits the cytotoxicity of the hardened composite corresponding to the standard requirements according to ISO 10993-5 and DIN EN ISO 7405, has the assessment “no cytotoxic potential”.

2 . Composition according to claim 1 , wherein the crosslinking agent moiety further comprises silorans.

3 . Composition according to claim 1 which is essentially free from bis-GMA.

Assignments (2)
CHANGE OF NAME Recorded Oct 20, 2017
From: HERAEUS KULZER GMBH
To: KULZER GMBH
Reel/Frame 044242/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2008
From: UTTERODT, ANDREAS, DR.; RUPPERT, KLAUS, DR.; SCHAUB, MATTHIAS, DR.; DIEFENBACH, CHRISTINE, MRS.; REISCHL, KURT; HOHMANN, ALFRED; ECK, MICHAEL; SCHONHOF, NELLI, MRS.
To: HERAEUS KULZER GMBH
Reel/Frame 020474/0115 →